Agilent Technologies

Premium

Agilent Technologies of Palo Alto, Calif., has received US Patent No. 6,974,703, "Electro-optical devices and methods for hybridization and detection." The patent claims an apparatus and method for detecting the presence of a target molecule. The apparatus comprises a probe labeled with a transition metal-ligand complex for hybridizing with the target to form an initial complex, metal ions for doping the initial complex and forming a final complex, and means to produce a detectable signal indicating the presence of the target.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.